CRL CHARLES RIVER LABORATORIES INT

Ownership history in DF DENT & CO INC  ·  10 quarters on record

This page tracks every 13F SEC filing in which DF DENT & CO INC reported a position in CHARLES RIVER LABORATORIES INT (CRL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.31% (2025 Q2)
Avg. % of fund
0.22%
First filed
2023 Q2
Last filed
2025 Q3
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 74,672 -87,788 -54.0% 0.15% $11.7M $156.46
2025 Q2 ADDED 162,460 +47,472 +41.3% 0.31% $24.7M $151.73
2025 Q1 ADDED 114,988 +2,458 +2.2% 0.23% $17.3M $150.52
2024 Q4 REDUCED 112,530 -7,515 -6.3% 0.26% $20.8M $184.60
2024 Q3 ADDED 120,045 +23,774 +24.7% 0.29% $23.6M $196.97
2024 Q2 ADDED 96,271 +28,918 +42.9% 0.26% $19.9M $206.58
2024 Q1 REDUCED 67,353 -428 -0.6% 0.22% $18.2M $270.95
2023 Q4 ADDED 67,781 +19,023 +39.0% 0.21% $16.0M $236.40
2023 Q3 REDUCED 48,758 -300 -0.6% 0.14% $9.6M $195.98
2023 Q2 INITIATED 49,058 0.14% $10.3M $210.25
% of Fund (quarterly)    CRL price (monthly, adj. close)
← Back to DF DENT & CO INC Holdings